PTEN: a novel anti-oncogenic function independent of phosphatase activity

Cell Cycle. 2005 Apr;4(4):540-2. doi: 10.4161/cc.4.4.1614. Epub 2005 Apr 21.

Abstract

The PTEN gene is an important tumor suppressor mutated in a number of cancers. To date, its growth regulatory properties have been intimately linked to its ability to act as a protein and phosphoinositol phosphatase. Inactivation of the enzymatic activity of PTEN is primarily due to direct mutation of its amino-terminal catalytic domain but approximately 20% of mutations are in the carboxy-terminus, which regulates membrane localization, protein stability, cellular migration and p53 function. We identified a novel protein that interacts with this domain, the v-jun transcriptional target, MSP58. Binding of MSP58 to PTEN results in the suppression of MSP58-mediated transformation. However, this PTEN effect does not require its catalytic activity, suggesting additional mechanisms of PTEN action.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Catalysis
  • Cell Cycle
  • Cell Membrane / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Genes, Tumor Suppressor*
  • Humans
  • Models, Biological
  • Nuclear Proteins / chemistry
  • PTEN Phosphohydrolase / chemistry*
  • PTEN Phosphohydrolase / metabolism
  • Phosphoric Monoester Hydrolases / chemistry
  • Phosphoric Monoester Hydrolases / metabolism*
  • RNA-Binding Proteins

Substances

  • MCRS1 protein, human
  • Nuclear Proteins
  • RNA-Binding Proteins
  • Phosphoric Monoester Hydrolases
  • PTEN Phosphohydrolase